﻿<?xml version="1.0" encoding="utf-8"?><rss version="2.0"><channel><title>Silicon Investor - Noven Pharmaceuticals (NOVN)</title><copyright>Copyright © 2026 Knight Sac Media.  All rights reserved.</copyright><link>https://www.siliconinvestor.com/subject.aspx?subjectid=16432</link><description>
 Noven is a leader in developing and manufacturing transdermal and transoral drug delivery systems.  These systems utilize an adhesive patch containing medication which, when adhered to the skin or the mucosa of the oral cavity, allows the delivery of drugs across the tissues and into the bloodstream over an extended period of time.  Noven has developed and patented thin, solid state, multi-laminate transdermal and transoral drug delivery systems that have a small surface area and  are adaptable to deliver numerous drug entities.  News:  biz.yahoo.com SEC:   sec.gov</description><image><url>https://www.siliconinvestor.com/images/Logo380x132.png</url><title>SI - Noven Pharmaceuticals (NOVN)</title><link>https://www.siliconinvestor.com/subject.aspx?subjectid=16432</link><width>380</width><height>132</height></image><ttl>10</ttl></channel></rss>